
A recent review highlights inflammation’s dual role in cancer progression and how emerging tools like AI and imaging biomarkers are enhancing personalized immunotherapy.
Key Details
- 1Chronic inflammation promotes tumorigenesis, survival, and therapy resistance, but can also suppress cancer depending on context.
- 2Key pathways: NF-κB, STAT3, IL-6, COX-2, and specific immune cells modulate the tumor microenvironment.
- 3Immunotherapies show varying efficacy (20–40% response rates); biomarkers like CRP, IL-6, and imaging data are key for patient stratification.
- 4Combination strategies (immunotherapy plus anti-inflammatories or microbiome modulators) are under clinical investigation.
- 5AI models incorporating imaging and multi-omic data are enabling real-time treatment personalization; Stanford’s 2024 model integrates imaging/text.
- 6Emerging tools include liquid biopsies, single-cell omics, gene editing, and nanotechnology for more precise disease monitoring.
Why It Matters

Source
EurekAlert
Related News

MSKAI Unveils AI Tool for Embryo Cell Analysis and Imaging-Driven Cancer Insights
MSK researchers employ AI and advanced imaging to reveal cancer mechanisms and track embryonic development at the single-cell level.

AI-Driven Home Sensors Enable Privacy-Preserving Health Emergency Detection
Researchers have developed an AI-powered home monitoring system using radar and thermal sensors to detect health emergencies and support elderly independent living.

New Study Urges 'Green AI' Practices in Medical Imaging and Healthcare
A new review highlights the urgent need for sustainable AI practices in healthcare, with emphasis on environmental impacts from applications like medical imaging.